Blog / Archives
Stocks to Watch: ASCO -continued-INCY, ONXX, SUPG
This is a continuation of pre-ASCO coverage, reviewing companies that will have significant clinical presentations on cancer products in their pipeline. Incyte Corporation (INCY $17.82) up 1.94%. is...
New: Guide to Biotech Investing and ETF’s
Our recent article on biotech investing and ETF's in general are posted on Investor Uprising. Note to get the article on the right side of the page you need to register at no charge for Investor...
Stocks to Watch: ASCO Presentations for ARIA,DNDN,ECYT and EXEL
Here is a brief review of stocks to watch with potential ASCO impact although it is likely that prices already reflect the scientific news: Ariad Pharmaceuticals Inc. (ARIA $8.43) up 0.36% will...
Medical Science News Ramping Up for ASCO
A bull market in life science stocks has revved up news for the upcoming ASCO Meeting on June 3 in Chicago. We will provide limited coverage of stocks to watch and scientific articles of interest....
Personalized Healthcare Gets a Boost from Nestle/Prometheus Deal
The Life Science market consolidation trend continued today as Nestle SA acquires privately held Prometheus Laboratories, Inc. of San Diego,CA for about $567M according to a Bloomberg story...
The Red Screen is the Winner Today But Cubist (CBST) Is Up On Buyout Rumors
It was a nasty day from the beginning but losses abated as the day wore on. The NASDAQ was off 1.68%, the Dow down 1.05% and the S&P down 1.15% to 1317. The S&P held trend lines in the...
ASCO June 3-7 Chicago: Rally Today
The pre-ASCO hype has already begun but many biopharma stocks have already run up 15%+ YTD. So it is time to be cautious as there may be an "ASCO Effect"- a sell on the news effect. Despite a weak...
Rayno Life Science Portfolio Winners Today: ABAX,CBST,CSII,NEOG
M&A Premium Rocks On In a flat life science market eclipsed by the LinkedIn (LNKD) IPO and its day trading frenzy, many life science stocks in the Rayno Life Science Portfolio logged decent...
GenProbe (GPRO) Sells Off After ThermoFisher (TMO) Announces Phadia Buyout
But ThermoFisher (TMO $65.12) is Up 3.78% on Volume of 3.2M Shares GenProbe (GPRO $84.10) down 2.9% sold off some of of the speculative gains from yesterday after ThermoFisherScientific (TMO)...
GenProbe (GPRO) up 8%+on Buy-Out Rumors
Speculation chat is driving up shares of GenProbe (GPRO) on heavier volume of 2.5M shares. Two stories are notable one from the Wall Street Journal on ThermoFisher (TMO) a potential bidder, but also...